Clinical Trial Update: A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Trafermin (fibroblast growth factor-2) for marginal periodontitis in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Trafermin (fibroblast growth factor-2 (FGF-2))

Snippet

Sponsor: Kaken Pharmaceutical | Conditions: Periodontitis | Phase 2 | Status: COMPLETED